Seth Klarman

Seth Klarman's The Baupost Group increases its position in Theravance, Inc. (NASDAQ:THRX) It now holds 13,000,000 shares, or 20.44%.

Baupost increases its position in Viasat (NASDAQ:VSAT), it now holds 8,706,700 shares, or 22.05%.

If you're interested in a blog about value investing inspired by Michael Burry and valuestocks.net please visit michaelburry.com

Baupost partially sells its stake in Facet Biotech (NASDAQ:FACT), now holds 2,000,000 shares, or 7.97%. FACT is up 54% YTD.

Seth Klarman's The Baupost Group increases its stake in Viasat (NASDAQ:VSAT) to 15.5%, or 4,915,901.

The Baupost Group increases its position in Theravance (NASDAQ:THRX). It now holds 10,100,000 shares, or 18.7%.

Baupost sells some of its stake on Syneron Medical (NASDAQ:ELOS). Now holds 1,500,000, or 5.45%.

The Baupost Group sells big share of stake on Sapphire Industrials (AMEX:FYR.UN). It now holds 2,250,000 down from 6,200,000 shares.

Baupost sells some of its stake on News Corp.(NASDAQ:NWSA), holding now 24,450,000 shares.

The Baupost Group increases its position on Enzon Pharmaceuticals (NASDAQ:ENZN). It now holds 8,082,400 shares, or 18%.

Baupost sells some of its stake on Domtar Corp. It now holds 2,900,000 shares, or 6.9%.

Seth Klarman's Baupost Group enters position in DirecTC (NASDAQ:DTV). Now holds 1,617,471 shares.

Baupost holds 2,582,186 shares of CIT Group (NYSE:CIT), or 1.3%.

The Baupost Group sells Capitalsource (NYSE:CSE) 4% notes, now holds 168,157,000 claims.

Baupost Increases its position in Capitalsource (NYSE:CSE). It now holds 20,278,400 shares, or 6.3%.

The Baupost Group files 13F-HR updates in positions to follow.

Just to clarify the previous tweet was due to 13d filing on December 28th

The Baupost Group sells all its stake in RHI Enertainment (NASDAQ:RHIE), or 4,900,551 shares representing 36% ownership.

Baupost files 13D/A on Facet holdings suggesting that they will not accept Biogen's $17.50 tender offer. FACT is 4.5% for the day at $17.12

Baupost sells 596,235 more shares of Syneron Medical (Nasdaq:ELOS) now holds 1,500,000 shares, or 5.45%. ELOS is up 19% YTD.